消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2022 NICE 质量标准：大肠癌

2022-02-01 英国国家卫生与临床优化研究所 NICE官网

消化道肿瘤大肠癌

该质量标准涵盖了成人结直肠癌（肠癌）的管理。它包括管理局部疾病和继发性肿瘤（转移性疾病）。它描述了需要改进的优先领域的高质量护理。

中文标题：

2022 NICE 质量标准：大肠癌

发布机构：

英国国家卫生与临床优化研究所

发布日期：

2022-02-01

简要介绍：

该质量标准涵盖了成人结直肠癌（肠癌）的管理。它包括管理局部疾病和继发性肿瘤（转移性疾病）。它描述了需要改进的优先领域的高质量护理。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 NICE 质量标准：大肠癌.pdf)] GetToolGuiderByIdResponse(projectId=1, id=da74f1c0023a5689, title=2022 NICE 质量标准：大肠癌, enTitle=, guiderFrom=NICE官网, authorId=0, author=, summary=该质量标准涵盖了成人结直肠癌（肠癌）的管理。它包括管理局部疾病和继发性肿瘤（转移性疾病）。它描述了需要改进的优先领域的高质量护理。, cover=https://img.medsci.cn/202226/1644078152655_1608702.png, journalId=0, articlesId=null, associationId=85, associationName=英国国家卫生与临床优化研究所, associationIntro=英国国家卫生与临床优化研究所（NICE，National Institute for Health and Clinical Excellence）是NHS的组织，设在伦敦和曼彻斯特。NICE成立于1999年4月1日，目标是确保每个英格兰和威尔士人平等享有NHS医疗的机会。NICE制定指南，设定质量标准，管理国家数据库，为NHS、当地权威部门和其他组织提供指南。, copyright=0, guiderPublishedTime=Tue Feb 01 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #0e0e0e;">该质量标准涵盖了成人结直肠癌（肠癌）的管理。</span><span style="color: #0e0e0e;">它包括管理局部疾病和继发性肿瘤（转移性疾病）。</span><span style="color: #0e0e0e;">它描述了需要改进的优先领域的高质量护理。</span></p>, tagList=[TagDto(tagId=439, tagName=消化道肿瘤), TagDto(tagId=1562, tagName=大肠癌)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3709, appHits=140, showAppHits=0, pcHits=456, showPcHits=3569, likes=0, shares=31, comments=4, approvalStatus=1, publishedTime=Sun Feb 06 15:18:00 CST 2022, publishedTimeString=2022-02-01, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Sun Feb 06 00:25:29 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sun Dec 31 07:07:17 CST 2023, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 NICE 质量标准：大肠癌.pdf)])
2022 NICE 质量标准：大肠癌.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1192276, encodeId=fc5611922e680, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e57b5438940, createdName=ms5000000321404738, createdTime=Fri Feb 11 12:11:35 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191562, encodeId=9a01119156267, content=学习了，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35465387413, createdName=ms8000002020716804, createdTime=Wed Feb 09 22:17:56 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191436, encodeId=0793119143699, content=学术经验, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Wed Feb 09 14:50:23 CST 2022, time=2022-02-09, status=1, ipAttribution=)]
    2022-02-11 ms5000000321404738

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1192276, encodeId=fc5611922e680, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e57b5438940, createdName=ms5000000321404738, createdTime=Fri Feb 11 12:11:35 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191562, encodeId=9a01119156267, content=学习了，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35465387413, createdName=ms8000002020716804, createdTime=Wed Feb 09 22:17:56 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191436, encodeId=0793119143699, content=学术经验, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Wed Feb 09 14:50:23 CST 2022, time=2022-02-09, status=1, ipAttribution=)]
    2022-02-09 ms8000002020716804

    学习了，谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1192276, encodeId=fc5611922e680, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e57b5438940, createdName=ms5000000321404738, createdTime=Fri Feb 11 12:11:35 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191562, encodeId=9a01119156267, content=学习了，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35465387413, createdName=ms8000002020716804, createdTime=Wed Feb 09 22:17:56 CST 2022, time=2022-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191436, encodeId=0793119143699, content=学术经验, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Wed Feb 09 14:50:23 CST 2022, time=2022-02-09, status=1, ipAttribution=)]
    2022-02-09 ms3000000637975859

    学术经验

    0

相关指南

近红外荧光成像在食管癌淋巴结清扫术中的应用专家共识（2021版）

中国医院协会介入医学中心分会 · 2021-11-25

胃癌卵巢转移诊断和治疗中国专家共识（2021版）

中国抗癌协会胃癌专业委员会 · 2022-01-01

2021 SBCO 指南：中低位直肠癌手术治疗

巴西肿瘤外科学会 (SBCO) · 2021-09-28

日本胰腺导管腺癌伴腹膜播散临床实践指南概要

日本肝胆胰腺外科学会(JSHBPS,Japanese Society of Hepato-Biliary-Pancreatic Surgery) · 2021-12-02

钇90微球管理专家共识

中国抗癌协会肿瘤介入学专业委员会 · 2021-06-10

2022 ASCRS临床实践指南：结肠癌的治疗

美国结肠和直肠外科医师学会(ASCRS,American Society of Colon and Rectal Surgeons) · 2022-01-10